Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria

Eur J Pharm Sci. 2020 Jan 1:141:105123. doi: 10.1016/j.ejps.2019.105123. Epub 2019 Oct 30.

Abstract

With the alarming burden of antibiotic resistance, antimicrobial peptides (AMPs) seem to be novel antimicrobial alternatives for infection treatment due to their rapid broad-spectrum antimicrobial activity and low tendency for bacterial resistance. To obtain promising AMPs, a series of new peptides were designed and synthesized by conjugating various lengths of fatty acid chains onto the side chain of the position 4 or 7 D-amino acid of Ano-D4,7 (analogue of anoplin with D-amino acid substitutions at positions 4 and 7). The new peptides exhibited excellent antimicrobial activity against a range of bacteria, especially multidrug-resistant bacteria in contrast to conventional antibiotics. Moreover, the new peptides conjugated with fatty acid chains ranging from 8 to 12 carbons in length presented preferable antimicrobial selectivity and anti-biofilm activity. Additionally, the new peptides also exerted high stability to trypsin, serum, salts and different pH environments. Most notably, the new peptides showed a low tendency to develop bacterial resistance and they displayed optimal antimicrobial activity against the obtained resistant strains. Furthermore, the results from the outer/inner membrane permeabilization and cytoplasmic membrane depolarization assays and flow cytometry and scanning electron microscopy analyses demonstrated that the new peptides exert antimicrobial effects by typical non-receptor-mediated membrane mechanisms, as well as intracellular targets characterized by gel retardation and reactive oxygen species (ROS) generation assays. Furthermore, the new peptides presented remarkable in vivo antimicrobial potency, anti-inflammatory activity, and endotoxin neutralization. Collectively, the conjugation of fatty acids to the side chains of D-amino acids is a potential strategy for designing hopeful antimicrobial alternatives to tackle the risk of bacterial resistance.

Keywords: Anoplin; Antimicrobial activity; Antimicrobial peptides; D-amino acid; Fatty acids conjugation; Hydrophobicity; Side chain.

MeSH terms

  • Amino Acids / administration & dosage*
  • Amino Acids / chemistry
  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / chemistry
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Cell Survival / drug effects
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Erythrocytes / drug effects
  • Fatty Acids / administration & dosage*
  • Fatty Acids / chemistry
  • Female
  • HEK293 Cells
  • HeLa Cells
  • Hemolysis / drug effects
  • Humans
  • Mice
  • Microbial Sensitivity Tests
  • Peptides / administration & dosage*
  • Peptides / chemistry

Substances

  • Amino Acids
  • Anti-Bacterial Agents
  • Fatty Acids
  • Peptides